Back

Activated factor XI is associated with recurrent venous thromboembolism in patients following pulmonary embolism: a cohort study

29 August 2026 (08:15 - 08:27)
Organised by: Logo
Congress Presentation Part of: Acute pulmonary embolism: risk and interventional therapies Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Patryk Stanislaw Michel

Krakow (Poland)

4 More presentations in this session

Presentation thumbnail
High-risk pe patients eligible for both large-bore mechanical thrombectomy and systemic thrombolysis: insights from the FLASH and FLAME Studies
Doctor L. Hobohm (Mainz, DE)
Abstract Slides
Presentation thumbnail
Patients with pulmonary embolism and cardiogenic shock benefit from interventional therapy rather than conventional thrombolytic therapy. A case analysis of all inpatients in Germany 2022 and 2025
Doctor S. Lange (Munster, DE)
Abstract Slides
Presentation thumbnail
Early respiratory–metabolic phenotypes predict 48-hour hemodynamic deterioration in intermediate-high risk pulmonary embolism
Doctor M. Zuin (Ferrara, IT)
Abstract Slides Video
Presentation thumbnail
Catheter-directed therapy in intermediate-high risk pulmonary embolism: which predictive factors for a favorable therapy response?
Doctor E. Blachere (Montpellier, FR)
Abstract Slides

Access the full session

Session thumbnail
Acute pulmonary embolism: risk and interventional therapies
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Risk factors of recurrence in patients with cancer-associated venous thromboembolism: from the COMMAND VTE Registry
28 August 2021
thumbnail
Congress Presentation
Valvular presence of coagulation factor XI correlates with the severity of aortic stenosis
26 August 2023
thumbnail
Congress Presentation
Prior anticoagulation experience, bleeding risk, and safety of factor XI inhibition in atrial fibrillation: an analysis of AZALEA-TIMI 71
1 September 2025
thumbnail
Congress Presentation
Redefining treatment paradigms for patients with acute pulmonary embolism and patent foramen ovale
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources